ADEL K EL-NAGGAR to Receptor, Notch1
This is a "connection" page, showing publications ADEL K EL-NAGGAR has written about Receptor, Notch1.
Connection Strength
0.724
-
A novel target for oral cancer chemoprevention? Notch quite, yet?. Cancer Prev Res (Phila). 2015 Apr; 8(4):262-5.
Score: 0.440
-
Activating NOTCH1 Mutations Define a Distinct Subgroup of Patients With Adenoid Cystic Carcinoma Who Have Poor Prognosis, Propensity to Bone and Liver Metastasis, and Potential Responsiveness to Notch1 Inhibitors. J Clin Oncol. 2017 Jan 20; 35(3):352-360.
Score: 0.124
-
Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science. 2011 Aug 26; 333(6046):1154-7.
Score: 0.086
-
Inhibition of the Phosphatidylinositol-3 Kinase Pathway Using Bimiralisib in Loss-of-Function NOTCH1-Mutant Head and Neck Cancer. Oncologist. 2022 12 09; 27(12):1004-e926.
Score: 0.047
-
A unifying gene signature for adenoid cystic cancer identifies parallel MYB-dependent and MYB-independent therapeutic targets. Oncotarget. 2014 Dec 30; 5(24):12528-42.
Score: 0.027